The first experience of using {99m}Tc-Al[2]O[3]-based radiopharmaceutical for the detection of sentinel lymph nodes in cervical cancer patients; AIP Conference Proceedings; Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016
| Parent link: | AIP Conference Proceedings Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016.— 2016.— [020060, 5 p.] |
|---|---|
| 団体著者: | |
| その他の著者: | , , , , , , |
| 要約: | Title screen The purpose of the study was to evaluate the feasibility of using {99m}Tc-Al[2]O[3]-based radiopharmaceutical,a novel molecular imaging agent for sentinel lymph node detection in patients with invasive cervical cancer. The study included 23 cervical cancer patients (T1aNxMx-T2bNxMx) treated at the Tomsk CancerResearch Institute. In the 18 hours before surgery, 80 MBq of the {99m}Tc-Al[2]O[3] in peritumoral injected, followed by single-photon emission computed tomography (SPECT) of the pelvis and intraoperative SLN identification. Twenty-seven SLNs were detected by SPECT, and 34 SLNs were identified by intraoperative gamma probe. The total number of identified SLNs per patient ranged from 1 to 3 (the mean number of SLNs was 1.4 per patient). The most common site for SLN detection was the external iliac region (57.2%), followed by the internal iliac (14%), obturator (14%), presacral and retrosacral regions (14%), and the parametrial region (1%). Sensitivity in detecting SLNs was 100% for intraoperative SLN identification and 79% for SPECT image. Режим доступа: по договору с организацией-держателем ресурса |
| 言語: | 英語 |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | http://dx.doi.org/10.1063/1.4960279 http://earchive.tpu.ru/handle/11683/35789 |
| フォーマット: | 電子媒体 図書の章 |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=652045 |
MARC
| LEADER | 00000nla2a2200000 4500 | ||
|---|---|---|---|
| 001 | 652045 | ||
| 005 | 20231101134711.0 | ||
| 035 | |a (RuTPU)RU\TPU\network\17308 | ||
| 035 | |a RU\TPU\network\17307 | ||
| 090 | |a 652045 | ||
| 100 | |a 20161130a2016 k y0engy50 ba | ||
| 101 | 0 | |a eng | |
| 105 | |a y z 100zy | ||
| 135 | |a drcn ---uucaa | ||
| 181 | 0 | |a i | |
| 182 | 0 | |a b | |
| 200 | 1 | |a The first experience of using {99m}Tc-Al[2]O[3]-based radiopharmaceutical for the detection of sentinel lymph nodes in cervical cancer patients |f I. G. Sinilkin [et al.] | |
| 203 | |a Text |c electronic | ||
| 300 | |a Title screen | ||
| 320 | |a [References: 11 tit.] | ||
| 330 | |a The purpose of the study was to evaluate the feasibility of using {99m}Tc-Al[2]O[3]-based radiopharmaceutical,a novel molecular imaging agent for sentinel lymph node detection in patients with invasive cervical cancer. The study included 23 cervical cancer patients (T1aNxMx-T2bNxMx) treated at the Tomsk CancerResearch Institute. In the 18 hours before surgery, 80 MBq of the {99m}Tc-Al[2]O[3] in peritumoral injected, followed by single-photon emission computed tomography (SPECT) of the pelvis and intraoperative SLN identification. Twenty-seven SLNs were detected by SPECT, and 34 SLNs were identified by intraoperative gamma probe. The total number of identified SLNs per patient ranged from 1 to 3 (the mean number of SLNs was 1.4 per patient). The most common site for SLN detection was the external iliac region (57.2%), followed by the internal iliac (14%), obturator (14%), presacral and retrosacral regions (14%), and the parametrial region (1%). Sensitivity in detecting SLNs was 100% for intraoperative SLN identification and 79% for SPECT image. | ||
| 333 | |a Режим доступа: по договору с организацией-держателем ресурса | ||
| 461 | 0 | |0 (RuTPU)RU\TPU\network\4816 |t AIP Conference Proceedings | |
| 463 | 0 | |0 (RuTPU)RU\TPU\network\17033 |t Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016 |o Proceedings of the International conference, 22-25 March 2016, Tomsk, Russia |f National Research Tomsk Polytechnic University (TPU) ; eds. E. Y. Gutmanas ; O. B. Naimark ; Yu. P. Sharkeev |v [020060, 5 p.] |d 2016 | |
| 610 | 1 | |a электронный ресурс | |
| 610 | 1 | |a труды учёных ТПУ | |
| 610 | 1 | |a радиофармпрепараты | |
| 610 | 1 | |a лимфатические узлы | |
| 610 | 1 | |a рак | |
| 610 | 1 | |a визуализация | |
| 610 | 1 | |a эмиссионная томография | |
| 610 | 1 | |a компьютерная томография | |
| 610 | 1 | |a злокачественные новообразования | |
| 610 | 1 | |a злокачественные опухоли | |
| 701 | 1 | |a Sinilkin |b I. G. |c specialist in the field of medical technology |c laboratory, Tomsk Polytechnic University, candidate of medical science |f 1972- |g Ivan Gennadjevich |2 stltpush |3 (RuTPU)RU\TPU\pers\34189 | |
| 701 | 1 | |a Chernov |b V. I. |c specialist in the field of medical technology |c lead engineer of Tomsk Polytechnic University, doctor of medical sciences |f 1962- |g Vladimir Ivanovich |2 stltpush |3 (RuTPU)RU\TPU\pers\34191 | |
| 701 | 1 | |a Lyapunov |b A. Yu. | |
| 701 | 1 | |a Medvedeva |b А. А. |c specialist in the field of medical technology |c laboratory assistant of Tomsk Polytechnic University, candidate of medical science |f 1975- |g Anna Aleksndrovna |2 stltpush |3 (RuTPU)RU\TPU\pers\37376 | |
| 701 | 1 | |a Zelchan |b R. V. |c specialist in the field of medical technology |c laboratory Tomsk Polytechnic University |f 1984- |g Roman Vladimirovich |2 stltpush |3 (RuTPU)RU\TPU\pers\34194 | |
| 701 | 1 | |a Chernyshova |b A. L. | |
| 701 | 1 | |a Kolomiets |b L. A. | |
| 712 | 0 | 2 | |a Национальный исследовательский Томский политехнический университет (ТПУ) |b Физико-технический институт (ФТИ) |b Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР) |h 6471 |2 stltpush |3 (RuTPU)RU\TPU\col\20054 |
| 801 | 2 | |a RU |b 63413507 |c 20170120 |g RCR | |
| 856 | 4 | |u http://dx.doi.org/10.1063/1.4960279 | |
| 856 | 4 | |u http://earchive.tpu.ru/handle/11683/35789 | |
| 942 | |c CF | ||